Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Current Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Total Current Liabilities ₹62 Cr₹109 Cr₹113 Cr₹78 Cr₹59 Cr

What is the latest Total Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹62 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹62 Cr
Mar2024₹109 Cr
Mar2023₹113 Cr
Mar2022₹78 Cr
Mar2017₹59 Cr

How is Total Current Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Current Liabilities % Change
Mar2025 ₹62 Cr
-43.19
Mar2024 ₹109 Cr
-3.89
Mar2023 ₹113 Cr
44.60
Mar2022 ₹78 Cr
33.01
Mar2017 ₹59 Cr -

Compare Total Current Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,274.6 Cr -5.6% 4.6% -22.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,827.0 Cr -0.5% 1.8% -2% Stock Analytics
DIVIS LABORATORIES ₹163,363.0 Cr -0.3% -1.3% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,193.0 Cr 4.4% 6% 27.7% Stock Analytics
CIPLA ₹109,519.0 Cr 1% -3% -8.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,940.0 Cr 1.1% 8% 3.8% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-5.6%

4.6%

-22.2%

SENSEX

-0.9%

-0.1%

7%


You may also like the below Video Courses